A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2004
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225015 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225007 Different physicochemical properties with different X-ray diffraction patterns; antiinflammatory and cytoprotective agent, treat diabetes mellitus and insulin resistance, glucose metabolic disorders of the central nervous system and appetite suppressant
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224976 Azabicyclic compounds for the treatment of disease
11/11/2004	US20040224970 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224965 Treatment of cardiovascular disorders, thrombosis, surgery and nhe inhibitors
11/11/2004	US20040224962 Treatment of obesity with drugs and to promote weight loss using nicotinic receptors
11/11/2004	US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis
11/11/2004	US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224902 Process for obtaining lignans
11/11/2004	US20040224898 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening
11/11/2004	US20040224360 Methods for diagnosing renal disorders
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224073 Soluble roasted chicory having high inulin content
11/11/2004	US20040224033 Side effect-relieving agents and/or hypoglycemic effect enhancers for thiazolidine compounds
11/11/2004	US20040223960 lipid hydrolyzing protein or polypeptide, particularly the protein lysosomal acid lipase; treating atherosclerosis, Wolman's Disease and Cholesteryl Ester Storage Disease
11/11/2004	DE19718245C5 Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung Synthetic triglycerides based on conjugated linoleic acid, processes for their preparation and their use
11/11/2004	CA2847543A1 Annatto extract compositions, including geranyl geraniols and methods of use
11/11/2004	CA2524457A1 Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
11/11/2004	CA2524251A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004	CA2524248A1 Angiotensin ii receptor blockers for preventing the development or progression of microvascular disease due to diabetes
11/11/2004	CA2524245A1 The use of azetidinecarboxamide derivatives in therapy
11/11/2004	CA2524175A1 Sugar intake-ability enhancer
11/11/2004	CA2524134A1 Adiponectin production enhancer
11/11/2004	CA2523763A1 Fused pyrimidine derivative
11/11/2004	CA2522895A1 Combined use of keratinocyte growth factor agonists and gastrin compounds
11/11/2004	CA2522868A1 Vector comprising gastric protection for oral administration
11/11/2004	CA2522708A1 Compositions for affecting weight loss
11/11/2004	CA2520842A1 Cannabinoid receptor ligands and uses thereof
11/10/2004	EP1475439A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier
11/10/2004	EP1475378A1 Antidiabetic thiazolidinedione potassium salt
11/10/2004	EP1475376A1 Hair composition containing a pyrimidine-n-oxide derivative and its use to stimulate keratinic fiberes growth and/or preventing their loss
11/10/2004	EP1475363A1 Method for stabilizing reduced coenzyme q 10 and composition therefor
11/10/2004	EP1475098A1 High-concentration preparation of soluble thrombomodulin
11/10/2004	EP1475095A1 Percutaneous preparations
11/10/2004	EP1475090A1 Drugs for mitochondrial diseases
11/10/2004	EP1475086A2 Sibutramine metabolites
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474414A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474398A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
11/10/2004	EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474394A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
11/10/2004	EP1474387A2 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
11/10/2004	EP1474385A1 Urea linker derivatives for use as ppar modulators
11/10/2004	EP1474174A1 Composition for oral or rectal administration
11/10/2004	EP1474164A2 Use of amylin agonists to modulate triglycerides
11/10/2004	EP1474163A2 Modification of feeding behavior
11/10/2004	EP1474162A1 Methods and compositions for the treatment of eye diseases
11/10/2004	EP1474157A1 Composition based on plant extracts for lowering and retaining blood sugar level
11/10/2004	EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1474142A2 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	EP1474138A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474132A1 Histamine-3 receptor ligands for diabetic conditions
11/10/2004	EP1474129A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
11/10/2004	EP1474119A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
11/10/2004	EP1474114A1 Oral dosage form for controlled drug release
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1198453B9 N-(indolcarbonyl-)piperazin derivatives
11/10/2004	EP1144389B1 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoicacid]calcium salt
11/10/2004	CN2654112Y Capsule for physical method reducing weight
11/10/2004	CN1545515A 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545421A Pharmaceutical compositions of drugs and neutralized acidic polymers
11/10/2004	CN1545415A Bone anabolic compounds and methods of use
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/10/2004	CN1545409A Use of stilbene compounds in preparing medicaments for treating and preventing diabetes or diseases associated with retrovirus
11/10/2004	CN1544429A Bee glue flavone extract preparation method, pharmaceutical preparation and its new medical uses
11/10/2004	CN1544084A Prolonged delivery of peptides
11/10/2004	CN1544083A Novel extract method for nutrient solution rich in protein polypeptide
11/10/2004	CN1544079A Composition contains spirulina mainly
11/10/2004	CN1544042A Liuwei Dihuang dripping pills and its preparation
11/10/2004	CN1544039A Fat-reducing speckle-removing cosmetic mixture and its capsule
11/10/2004	CN1543999A Chinese traditional medicine preparation for treating cardiac and cerebral vascular diseases and its preparation process
11/10/2004	CN1543984A Strontium-calcium composite tonic series and its preparation
11/10/2004	CN1543980A Mohailin dripping pills and its preparation
11/10/2004	CN1543978A Highly concentration water-soluble vitamin for intravenous injection and preparation and use
11/10/2004	CN1543977A Medicine for treating cerebrovascular and cardiovascular diseases and preparation process thereof
11/10/2004	CN1543968A Drug prepared by mulberry bark extract
11/10/2004	CN1543942A Haw leaf general flavone soft capsule and preparation thereof

1 ... 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 ... 1298